# The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

> **NCT07211126** · — · RECRUITING · sponsor: **Tandem Diabetes Care, Inc.** · enrollment: 350 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** t:slim X2 insulin pump with Control-IQ technology (Control-IQ System)

## Key facts

- **NCT ID:** NCT07211126
- **Lead sponsor:** Tandem Diabetes Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-03
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211126, "The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07211126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*